封面
市場調查報告書
商品編碼
1212029

生命科學分析的全球市場

Life Science Analytics

出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 193 Pages | 商品交期: 最快1-2個工作天內

價格

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

全球生命科學分析的市場規模預測將從2022年的244億美元,到2030年達到667億美元,在2022年~2030年間預計將以13.4%的年複合成長率增長。

本報告提供全球生命科學分析市場相關調查分析,提供市場趨勢與推動因素,預測,地區分析,競爭情形等資訊。

調查對像企業範例(全44公司):

  • Accenture PLC
  • Cognizant Technology Solutions Corporation
  • IBM Corporation
  • IQVIA
  • MaxisIT Inc.
  • Oracle Corporation
  • SAS Institute, Inc.
  • SCIO Health Analytics, an EXL company
  • TAKE Solutions
  • Wipro Ltd.

目錄

第1章 調查手法

第2章 摘要整理

  • 市場概要
  • 主要企業
  • 市場趨勢與推動因素
  • 全球市場預測

第3章 市場分析

  • 美國
  • 加拿大
  • 日本
  • 中國
  • 歐洲
  • 法國
  • 德國
  • 義大利
  • 英國
  • 其他歐洲
  • 亞太地區
  • 其他地區

第4章 競爭

簡介目錄
Product Code: MCP13011

What`s New for 2023?

»Special coverage on Russia-Ukraine war; global inflation; easing of "zero-Covid" policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.

»Global competitiveness and key competitor percentage market shares

» Market presence across multiple geographies - Strong/Active/Niche/Trivial

»Online interactive peer-to-peer collaborative bespoke updates

»Access to our digital archives and MarketGlass Research Platform

»Complimentary updates for one year

Looking Ahead to 2023

The global economy is at a critical crossroads with a number of interlocking challenges and crises running in parallel. The uncertainty around how Russia`s war on Ukraine will play out this year and the war`s role in creating global instability means that the trouble on the inflation front is not over yet. Food and fuel inflation will remain a persistent economic problem. Higher retail inflation will impact consumer confidence and spending. As governments combat inflation by raising interest rates, new job creation will slowdown and impact economic activity and growth. Lower capital expenditure is in the offing as companies go slow on investments, held back by inflation worries and weaker demand. With slower growth and high inflation, developed markets seem primed to enter into a recession. Fears of new COVID outbreaks and China's already uncertain post-pandemic path poses a real risk of the world experiencing more acute supply chain pain and manufacturing disruptions this year. Volatile financial markets, growing trade tensions, stricter regulatory environment and pressure to mainstream climate change into economic decisions will compound the complexity of challenges faced. Year 2023 is expected to be tough year for most markets, investors and consumers. Nevertheless, there is always opportunity for businesses and their leaders who can chart a path forward with resilience and adaptability.

Global Life Science Analytics Market to Reach $66.7 Billion by 2030

In the changed post COVID-19 business landscape, the global market for Life Science Analytics estimated at US$24.4 Billion in the year 2022, is projected to reach a revised size of US$66.7 Billion by 2030, growing at aCAGR of 13.4% over the period 2022-2030. Services, one of the segments analyzed in the report, is projected to record 14.2% CAGR and reach US$40.1 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Software segment is readjusted to a revised 12.4% CAGR for the next 8-year period.

The U.S. Market is Estimated at $7.1 Billion, While China is Forecast to Grow at 12.4% CAGR

The Life Science Analytics market in the U.S. is estimated at US$7.1 Billion in the year 2022. China, the world`s second largest economy, is forecast to reach a projected market size of US$11.2 Billion by the year 2030 trailing a CAGR of 12.4% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 12.2% and 11.4% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 9.5% CAGR.

Select Competitors (Total 44 Featured):

  • Accenture PLC
  • Cognizant Technology Solutions Corporation
  • IBM Corporation
  • IQVIA
  • MaxisIT Inc.
  • Oracle Corporation
  • SAS Institute, Inc.
  • SCIO Health Analytics, an EXL company
  • TAKE Solutions
  • Wipro Ltd.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Impact of COVID-19 Pandemic & Looming Global Recession
    • An Introduction to Life Science Analytics
    • Global Market Prospects & Outlook
    • Descriptive Analytics: The Largest Segment
    • Sales & Marketing Application Poised for High Growth
    • China & Asia-Pacific to Spearhead Future Market Growth
    • Life Science Analytics - Global Key Competitors Percentage Market Share in 2022 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Technology Advancements Fuel Market Growth
    • Rising Relevance of Big Data Analytics to Improve Productivity in Life Science Industry
    • Analytics Solutions Find Increasing Adoption in Clinical Trials
    • Rise in Pharmaceutical R&D Spending to Boost Adoption of Analytics in Clinical Research Institutions
    • Pharmaceutical R&D Spending (in US$ Billion) for 2010-2020
    • Leading Pharmaceutical Companies Ranked by R&D Spending
    • AI, ML & Big Data Transform Clinical Trials Market
    • Increasing Prevalence of Chronic Diseases Boosts Market Prospects
    • Need to Curb Surging Healthcare Spending & Improve Patient Outcomes Enhance Importance of Analytics
    • Growing Use of Analytics in Personalized and Precision Medicine: A Major Growth Opportunity
    • Global Precision Medicine Market Size (US$ Billion) for the Years 2019, 2022 and 2025
    • Need for Better Data Standardization Spurs Need for Analytics Solutions in Life Science Industry
    • Rising Prominence of Value-Based Medicine Presents Opportunity for Market Growth
    • High Implementation Costs, Privacy Concerns & Workforce Shortage: Key Challenges for the Market
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Life Science Analytics Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Life Science Analytics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 3: World 8-Year Perspective for Life Science Analytics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2023 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 5: World 8-Year Perspective for Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
    • TABLE 6: World Recent Past, Current & Future Analysis for Software by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 7: World 8-Year Perspective for Software by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Descriptive Analytics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 9: World 8-Year Perspective for Descriptive Analytics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Predictive Analytics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 11: World 8-Year Perspective for Predictive Analytics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
    • TABLE 12: World Recent Past, Current & Future Analysis for Prescriptive Analytics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 13: World 8-Year Perspective for Prescriptive Analytics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for On-Premise by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 15: World 8-Year Perspective for On-Premise by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Cloud by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 17: World 8-Year Perspective for Cloud by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
    • TABLE 18: World Recent Past, Current & Future Analysis for Pharma & Biotech Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 19: World 8-Year Perspective for Pharma & Biotech Companies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Medical Device Manufacturers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 21: World 8-Year Perspective for Medical Device Manufacturers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
    • TABLE 22: World Recent Past, Current & Future Analysis for Research Facilities by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 23: World 8-Year Perspective for Research Facilities by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
    • TABLE 24: World Recent Past, Current & Future Analysis for Third-Party Administrators by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 25: World 8-Year Perspective for Third-Party Administrators by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Life Science Analytics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2023 (E)
    • TABLE 26: USA Recent Past, Current & Future Analysis for Life Science Analytics by Type - Descriptive Analytics, Predictive Analytics and Prescriptive Analytics - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 27: USA 8-Year Perspective for Life Science Analytics by Type - Percentage Breakdown of Value Sales for Descriptive Analytics, Predictive Analytics and Prescriptive Analytics for the Years 2023 & 2030
    • TABLE 28: USA Recent Past, Current & Future Analysis for Life Science Analytics by Offering - Services and Software - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 29: USA 8-Year Perspective for Life Science Analytics by Offering - Percentage Breakdown of Value Sales for Services and Software for the Years 2023 & 2030
    • TABLE 30: USA Recent Past, Current & Future Analysis for Life Science Analytics by Deployment - On-Premise and Cloud - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 31: USA 8-Year Perspective for Life Science Analytics by Deployment - Percentage Breakdown of Value Sales for On-Premise and Cloud for the Years 2023 & 2030
    • TABLE 32: USA Recent Past, Current & Future Analysis for Life Science Analytics by End-Use - Pharma & Biotech Companies, Medical Device Manufacturers, Research Facilities and Third-Party Administrators - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 33: USA 8-Year Perspective for Life Science Analytics by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Medical Device Manufacturers, Research Facilities and Third-Party Administrators for the Years 2023 & 2030
  • CANADA
    • TABLE 34: Canada Recent Past, Current & Future Analysis for Life Science Analytics by Type - Descriptive Analytics, Predictive Analytics and Prescriptive Analytics - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 35: Canada 8-Year Perspective for Life Science Analytics by Type - Percentage Breakdown of Value Sales for Descriptive Analytics, Predictive Analytics and Prescriptive Analytics for the Years 2023 & 2030
    • TABLE 36: Canada Recent Past, Current & Future Analysis for Life Science Analytics by Offering - Services and Software - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 37: Canada 8-Year Perspective for Life Science Analytics by Offering - Percentage Breakdown of Value Sales for Services and Software for the Years 2023 & 2030
    • TABLE 38: Canada Recent Past, Current & Future Analysis for Life Science Analytics by Deployment - On-Premise and Cloud - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 39: Canada 8-Year Perspective for Life Science Analytics by Deployment - Percentage Breakdown of Value Sales for On-Premise and Cloud for the Years 2023 & 2030
    • TABLE 40: Canada Recent Past, Current & Future Analysis for Life Science Analytics by End-Use - Pharma & Biotech Companies, Medical Device Manufacturers, Research Facilities and Third-Party Administrators - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 41: Canada 8-Year Perspective for Life Science Analytics by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Medical Device Manufacturers, Research Facilities and Third-Party Administrators for the Years 2023 & 2030
  • JAPAN
    • Life Science Analytics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2023 (E)
    • TABLE 42: Japan Recent Past, Current & Future Analysis for Life Science Analytics by Type - Descriptive Analytics, Predictive Analytics and Prescriptive Analytics - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 43: Japan 8-Year Perspective for Life Science Analytics by Type - Percentage Breakdown of Value Sales for Descriptive Analytics, Predictive Analytics and Prescriptive Analytics for the Years 2023 & 2030
    • TABLE 44: Japan Recent Past, Current & Future Analysis for Life Science Analytics by Offering - Services and Software - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 45: Japan 8-Year Perspective for Life Science Analytics by Offering - Percentage Breakdown of Value Sales for Services and Software for the Years 2023 & 2030
    • TABLE 46: Japan Recent Past, Current & Future Analysis for Life Science Analytics by Deployment - On-Premise and Cloud - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 47: Japan 8-Year Perspective for Life Science Analytics by Deployment - Percentage Breakdown of Value Sales for On-Premise and Cloud for the Years 2023 & 2030
    • TABLE 48: Japan Recent Past, Current & Future Analysis for Life Science Analytics by End-Use - Pharma & Biotech Companies, Medical Device Manufacturers, Research Facilities and Third-Party Administrators - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 49: Japan 8-Year Perspective for Life Science Analytics by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Medical Device Manufacturers, Research Facilities and Third-Party Administrators for the Years 2023 & 2030
  • CHINA
    • Life Science Analytics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2023 (E)
    • TABLE 50: China Recent Past, Current & Future Analysis for Life Science Analytics by Type - Descriptive Analytics, Predictive Analytics and Prescriptive Analytics - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 51: China 8-Year Perspective for Life Science Analytics by Type - Percentage Breakdown of Value Sales for Descriptive Analytics, Predictive Analytics and Prescriptive Analytics for the Years 2023 & 2030
    • TABLE 52: China Recent Past, Current & Future Analysis for Life Science Analytics by Offering - Services and Software - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 53: China 8-Year Perspective for Life Science Analytics by Offering - Percentage Breakdown of Value Sales for Services and Software for the Years 2023 & 2030
    • TABLE 54: China Recent Past, Current & Future Analysis for Life Science Analytics by Deployment - On-Premise and Cloud - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 55: China 8-Year Perspective for Life Science Analytics by Deployment - Percentage Breakdown of Value Sales for On-Premise and Cloud for the Years 2023 & 2030
    • TABLE 56: China Recent Past, Current & Future Analysis for Life Science Analytics by End-Use - Pharma & Biotech Companies, Medical Device Manufacturers, Research Facilities and Third-Party Administrators - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 57: China 8-Year Perspective for Life Science Analytics by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Medical Device Manufacturers, Research Facilities and Third-Party Administrators for the Years 2023 & 2030
  • EUROPE
    • Life Science Analytics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2023 (E)
    • TABLE 58: Europe Recent Past, Current & Future Analysis for Life Science Analytics by Type - Descriptive Analytics, Predictive Analytics and Prescriptive Analytics - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 59: Europe 8-Year Perspective for Life Science Analytics by Type - Percentage Breakdown of Value Sales for Descriptive Analytics, Predictive Analytics and Prescriptive Analytics for the Years 2023 & 2030
    • TABLE 60: Europe Recent Past, Current & Future Analysis for Life Science Analytics by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 61: Europe 8-Year Perspective for Life Science Analytics by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2023 & 2030
    • TABLE 62: Europe Recent Past, Current & Future Analysis for Life Science Analytics by Offering - Services and Software - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 63: Europe 8-Year Perspective for Life Science Analytics by Offering - Percentage Breakdown of Value Sales for Services and Software for the Years 2023 & 2030
    • TABLE 64: Europe Recent Past, Current & Future Analysis for Life Science Analytics by Deployment - On-Premise and Cloud - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 65: Europe 8-Year Perspective for Life Science Analytics by Deployment - Percentage Breakdown of Value Sales for On-Premise and Cloud for the Years 2023 & 2030
    • TABLE 66: Europe Recent Past, Current & Future Analysis for Life Science Analytics by End-Use - Pharma & Biotech Companies, Medical Device Manufacturers, Research Facilities and Third-Party Administrators - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 67: Europe 8-Year Perspective for Life Science Analytics by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Medical Device Manufacturers, Research Facilities and Third-Party Administrators for the Years 2023 & 2030
  • FRANCE
    • Life Science Analytics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2023 (E)
    • TABLE 68: France Recent Past, Current & Future Analysis for Life Science Analytics by Type - Descriptive Analytics, Predictive Analytics and Prescriptive Analytics - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 69: France 8-Year Perspective for Life Science Analytics by Type - Percentage Breakdown of Value Sales for Descriptive Analytics, Predictive Analytics and Prescriptive Analytics for the Years 2023 & 2030
    • TABLE 70: France Recent Past, Current & Future Analysis for Life Science Analytics by Offering - Services and Software - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 71: France 8-Year Perspective for Life Science Analytics by Offering - Percentage Breakdown of Value Sales for Services and Software for the Years 2023 & 2030
    • TABLE 72: France Recent Past, Current & Future Analysis for Life Science Analytics by Deployment - On-Premise and Cloud - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 73: France 8-Year Perspective for Life Science Analytics by Deployment - Percentage Breakdown of Value Sales for On-Premise and Cloud for the Years 2023 & 2030
    • TABLE 74: France Recent Past, Current & Future Analysis for Life Science Analytics by End-Use - Pharma & Biotech Companies, Medical Device Manufacturers, Research Facilities and Third-Party Administrators - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 75: France 8-Year Perspective for Life Science Analytics by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Medical Device Manufacturers, Research Facilities and Third-Party Administrators for the Years 2023 & 2030
  • GERMANY
    • Life Science Analytics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2023 (E)
    • TABLE 76: Germany Recent Past, Current & Future Analysis for Life Science Analytics by Type - Descriptive Analytics, Predictive Analytics and Prescriptive Analytics - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 77: Germany 8-Year Perspective for Life Science Analytics by Type - Percentage Breakdown of Value Sales for Descriptive Analytics, Predictive Analytics and Prescriptive Analytics for the Years 2023 & 2030
    • TABLE 78: Germany Recent Past, Current & Future Analysis for Life Science Analytics by Offering - Services and Software - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 79: Germany 8-Year Perspective for Life Science Analytics by Offering - Percentage Breakdown of Value Sales for Services and Software for the Years 2023 & 2030
    • TABLE 80: Germany Recent Past, Current & Future Analysis for Life Science Analytics by Deployment - On-Premise and Cloud - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 81: Germany 8-Year Perspective for Life Science Analytics by Deployment - Percentage Breakdown of Value Sales for On-Premise and Cloud for the Years 2023 & 2030
    • TABLE 82: Germany Recent Past, Current & Future Analysis for Life Science Analytics by End-Use - Pharma & Biotech Companies, Medical Device Manufacturers, Research Facilities and Third-Party Administrators - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 83: Germany 8-Year Perspective for Life Science Analytics by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Medical Device Manufacturers, Research Facilities and Third-Party Administrators for the Years 2023 & 2030
  • ITALY
    • TABLE 84: Italy Recent Past, Current & Future Analysis for Life Science Analytics by Type - Descriptive Analytics, Predictive Analytics and Prescriptive Analytics - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 85: Italy 8-Year Perspective for Life Science Analytics by Type - Percentage Breakdown of Value Sales for Descriptive Analytics, Predictive Analytics and Prescriptive Analytics for the Years 2023 & 2030
    • TABLE 86: Italy Recent Past, Current & Future Analysis for Life Science Analytics by Offering - Services and Software - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 87: Italy 8-Year Perspective for Life Science Analytics by Offering - Percentage Breakdown of Value Sales for Services and Software for the Years 2023 & 2030
    • TABLE 88: Italy Recent Past, Current & Future Analysis for Life Science Analytics by Deployment - On-Premise and Cloud - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 89: Italy 8-Year Perspective for Life Science Analytics by Deployment - Percentage Breakdown of Value Sales for On-Premise and Cloud for the Years 2023 & 2030
    • TABLE 90: Italy Recent Past, Current & Future Analysis for Life Science Analytics by End-Use - Pharma & Biotech Companies, Medical Device Manufacturers, Research Facilities and Third-Party Administrators - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 91: Italy 8-Year Perspective for Life Science Analytics by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Medical Device Manufacturers, Research Facilities and Third-Party Administrators for the Years 2023 & 2030
  • UNITED KINGDOM
    • Life Science Analytics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2023 (E)
    • TABLE 92: UK Recent Past, Current & Future Analysis for Life Science Analytics by Type - Descriptive Analytics, Predictive Analytics and Prescriptive Analytics - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 93: UK 8-Year Perspective for Life Science Analytics by Type - Percentage Breakdown of Value Sales for Descriptive Analytics, Predictive Analytics and Prescriptive Analytics for the Years 2023 & 2030
    • TABLE 94: UK Recent Past, Current & Future Analysis for Life Science Analytics by Offering - Services and Software - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 95: UK 8-Year Perspective for Life Science Analytics by Offering - Percentage Breakdown of Value Sales for Services and Software for the Years 2023 & 2030
    • TABLE 96: UK Recent Past, Current & Future Analysis for Life Science Analytics by Deployment - On-Premise and Cloud - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 97: UK 8-Year Perspective for Life Science Analytics by Deployment - Percentage Breakdown of Value Sales for On-Premise and Cloud for the Years 2023 & 2030
    • TABLE 98: UK Recent Past, Current & Future Analysis for Life Science Analytics by End-Use - Pharma & Biotech Companies, Medical Device Manufacturers, Research Facilities and Third-Party Administrators - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 99: UK 8-Year Perspective for Life Science Analytics by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Medical Device Manufacturers, Research Facilities and Third-Party Administrators for the Years 2023 & 2030
  • REST OF EUROPE
    • TABLE 100: Rest of Europe Recent Past, Current & Future Analysis for Life Science Analytics by Type - Descriptive Analytics, Predictive Analytics and Prescriptive Analytics - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 101: Rest of Europe 8-Year Perspective for Life Science Analytics by Type - Percentage Breakdown of Value Sales for Descriptive Analytics, Predictive Analytics and Prescriptive Analytics for the Years 2023 & 2030
    • TABLE 102: Rest of Europe Recent Past, Current & Future Analysis for Life Science Analytics by Offering - Services and Software - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 103: Rest of Europe 8-Year Perspective for Life Science Analytics by Offering - Percentage Breakdown of Value Sales for Services and Software for the Years 2023 & 2030
    • TABLE 104: Rest of Europe Recent Past, Current & Future Analysis for Life Science Analytics by Deployment - On-Premise and Cloud - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 105: Rest of Europe 8-Year Perspective for Life Science Analytics by Deployment - Percentage Breakdown of Value Sales for On-Premise and Cloud for the Years 2023 & 2030
    • TABLE 106: Rest of Europe Recent Past, Current & Future Analysis for Life Science Analytics by End-Use - Pharma & Biotech Companies, Medical Device Manufacturers, Research Facilities and Third-Party Administrators - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 107: Rest of Europe 8-Year Perspective for Life Science Analytics by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Medical Device Manufacturers, Research Facilities and Third-Party Administrators for the Years 2023 & 2030
  • ASIA-PACIFIC
    • Life Science Analytics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2023 (E)
    • TABLE 108: Asia-Pacific Recent Past, Current & Future Analysis for Life Science Analytics by Type - Descriptive Analytics, Predictive Analytics and Prescriptive Analytics - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 109: Asia-Pacific 8-Year Perspective for Life Science Analytics by Type - Percentage Breakdown of Value Sales for Descriptive Analytics, Predictive Analytics and Prescriptive Analytics for the Years 2023 & 2030
    • TABLE 110: Asia-Pacific Recent Past, Current & Future Analysis for Life Science Analytics by Offering - Services and Software - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 111: Asia-Pacific 8-Year Perspective for Life Science Analytics by Offering - Percentage Breakdown of Value Sales for Services and Software for the Years 2023 & 2030
    • TABLE 112: Asia-Pacific Recent Past, Current & Future Analysis for Life Science Analytics by Deployment - On-Premise and Cloud - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 113: Asia-Pacific 8-Year Perspective for Life Science Analytics by Deployment - Percentage Breakdown of Value Sales for On-Premise and Cloud for the Years 2023 & 2030
    • TABLE 114: Asia-Pacific Recent Past, Current & Future Analysis for Life Science Analytics by End-Use - Pharma & Biotech Companies, Medical Device Manufacturers, Research Facilities and Third-Party Administrators - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 115: Asia-Pacific 8-Year Perspective for Life Science Analytics by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Medical Device Manufacturers, Research Facilities and Third-Party Administrators for the Years 2023 & 2030
  • REST OF WORLD
    • TABLE 116: Rest of World Recent Past, Current & Future Analysis for Life Science Analytics by Type - Descriptive Analytics, Predictive Analytics and Prescriptive Analytics - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 117: Rest of World 8-Year Perspective for Life Science Analytics by Type - Percentage Breakdown of Value Sales for Descriptive Analytics, Predictive Analytics and Prescriptive Analytics for the Years 2023 & 2030
    • TABLE 118: Rest of World Recent Past, Current & Future Analysis for Life Science Analytics by Offering - Services and Software - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 119: Rest of World 8-Year Perspective for Life Science Analytics by Offering - Percentage Breakdown of Value Sales for Services and Software for the Years 2023 & 2030
    • TABLE 120: Rest of World Recent Past, Current & Future Analysis for Life Science Analytics by Deployment - On-Premise and Cloud - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 121: Rest of World 8-Year Perspective for Life Science Analytics by Deployment - Percentage Breakdown of Value Sales for On-Premise and Cloud for the Years 2023 & 2030
    • TABLE 122: Rest of World Recent Past, Current & Future Analysis for Life Science Analytics by End-Use - Pharma & Biotech Companies, Medical Device Manufacturers, Research Facilities and Third-Party Administrators - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 123: Rest of World 8-Year Perspective for Life Science Analytics by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Medical Device Manufacturers, Research Facilities and Third-Party Administrators for the Years 2023 & 2030

IV. COMPETITION